Performance analysis of AL amyloidosis cardiac biomarker staging systems with special focus on renal failure and atrial arrhythmia

Systemic light chain amyloidosis is a rare and life-threatening disorder, for which accurate risk stratification is crucial. Current cardiac staging systems (MAYO2004, MAYO3b, and MAYO2012) are mainly based on biomarkers, which have uncertain reliability in the context of atrial fibrillation, arrhyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Dittrich, Tobias, Benner, Axel, Kimmich, Christoph, Siepen, Fabian aus dem, Veelken, Kaya, Kristen, Arnt V., Bochtler, Tilmann, Katus, Hugo A., Müller-Tidow, Carsten, Hegenbart, Ute, Schönland, Stefan O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601086/
https://www.ncbi.nlm.nih.gov/pubmed/30655373
http://dx.doi.org/10.3324/haematol.2018.205336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601086/
https://www.ncbi.nlm.nih.gov/pubmed/30655373
http://dx.doi.org/10.3324/haematol.2018.205336

Ejemplares similares